Does Wider Losses Change The Bull Case For Trevi Therapeutics Stock (TRVI)?
Trevi Therapeutics, Inc. Q3 2026 Earnings Call Summary
Trevi Therapeutics Inc (TRVI) Q3 2026 Earnings Call Highlights: Strong Cash Position, FDA ...
Trevi Therapeutics (TRVI) Q3 2026 Earnings Call Transcript
What Trevi Therapeutics (TRVI) Said on Its Q3 Earnings Call
Trevi Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Updates
Trevi Therapeutics, Inc. (TRVI) Q3 2026 Earnings Call Transcript
Trevi Therapeutics Q3 2026 Earnings Call Transcript
Trevi Therapeutics Q3 EPS $(0.13), Inline
Trevi Therapeutics to Report Third Quarter 2026 Financial Results and Provide a Corporate Update on November 9, 2026
Trevi Therapeutics (TRVI) Stock May Still Look Expensive Against Book Value
Trevi Therapeutics to Participate in Stifel's 2026 Healthcare Conference
Do Trevi Therapeutics’ (TRVI) CORAL Data and GSK’s Exit Reframe Its Chronic Cough Ambitions?
Trevi Therapeutics Announces Oral Presentation Accepted at the CHEST 2026 Annual Meeting
Trevi Therapeutics Announces Results From Phase 2b CORAL Trial Accepted As Oral Presentation At CHEST 2026 Annual Meeting Of American College Of Chest Physicians
Trevi Therapeutics Q2 2026 Earnings Call Transcript
Trevi Therapeutics, Inc. (TRVI) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Trevi Therapeutics (TRVI) Stock Trades At A Premium To Fair Value
Trevi Therapeutics to Participate in Upcoming September Conferences
Trevi Therapeutics Announces Upcoming Presentations at the European Respiratory Society (ERS) Congress 2026
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.